Results 181 to 190 of about 242,918 (218)

Stereotactic ablative radiotherapy: what's in a name?

Practical Radiation Oncology, 2011
Department of Radiation Oncology, Stanford University and Cancer Center, Stanford, California Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas Department of Radiation Oncology, University of Toronto/Princess Margaret Hospital, Toronto, Ontario, Canada Department of Radiation Oncology, University of ...
Loo, Billy W., Chang, Joe Y., Dawson, Laura A., Kavanagh, Brian D., Koong, Albert C., Senan, Suresh, Timmerman, Robert D.   +6 more
openaire   +2 more sources

Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases

JAMA Oncology, 2020
Rising cancer incidence combined with improvements in systemic and local therapies extending life expectancy are translating into more patients with spinal metastases. This makes the multidisciplinary management of spinal metastases and development of new therapies increasingly important. Spinal metastases may cause significant pain and reduced quality
Rachel M, Glicksman, Michael C, Tjong, Wellington F P, Neves-Junior, Daniel E, Spratt, Kevin L M, Chua, Alireza, Mansouri, Melvin L K, Chua, Alejandro, Berlin, Jeff D, Winter, Max, Dahele, Ben J, Slotman, Mark, Bilsky, David B, Shultz, Marcos, Maldaun, Nicholas, Szerlip, Simon S, Lo, Yoshiya, Yamada, Francisco Emilio, Vera-Badillo, Gustavo N, Marta, Fabio Y, Moraes   +19 more
openaire   +2 more sources

Non-invasive ablation of arrhythmias with stereotactic ablative radiotherapy

Trends in Cardiovascular Medicine, 2022
Stereotactic ablative radiotherapy (SABR), or stereotactic body radiotherapy (SBRT), has recently been applied in the field of arrhythmia management. It has been most widely assessed in the treatment of ventricular tachycardia (VT) but may also have potential in the treatment of other arrhythmias as well, often termed stereotactic arrhythmia ...
John Whitaker, Raymond H. Mak, Paul C. Zei   +2 more
openaire   +2 more sources

Stereotactic Ablative Body Radiotherapy for Lung Cancer

Clinical Oncology, 2015
Lung stereotactic ablative radiotherapy (SABR) is a method of delivering high 'ablative' doses of radiotherapy to tumours in the lung. It was developed at the Karolinska Institute in the early 1990s using the methods established in cranial radiosurgery with multiple beams prescribed to an isodose and using a custom designed stereotactic body frame for ...
K N, Franks, P, Jain, M P, Snee
openaire   +2 more sources

Comparing the Outcomes of Stereotactic Ablative Radiotherapy and Non-Stereotactic Ablative Radiotherapy Definitive Radiotherapy Approaches to Thoracic Malignancy

Clinical Lung Cancer, 2018
Stereotactic ablative body radiotherapy (SABR) is popular because of the high rates of local control with low toxicity seen in lung cancer patients. In this study we compared clinically significant toxicity and overall survival for SABR and non-SABR definitive radiotherapy (conformal radiotherapy) patients.
Hegi, Fiona, D'Souza, Mario, Azzi, Maria, De Ruysscher, Dirk   +3 more
openaire   +3 more sources

Stereotactic ablative radiotherapy for colorectal cancer liver metastasis

Seminars in Cancer Biology, 2021
Survival improvement of colorectal liver metastasis (CRLM) benefits from systemic therapy and metastasis-directed local therapy. Stereotactic ablative body radiotherapy (SABR), as a new efficient metastasis-directed local therapy with a systematic impact, plays a vital role in CRLM multidisciplinary treatment.
Hao Wang, Xuemin Li, Ran Peng, Yuxia Wang, Junjie Wang   +4 more
openaire   +2 more sources

Stereotactic Body Radiotherapy/Stereotactic Ablative Body Radiotherapy for Lung Cancer

2013
Technological advances in radiation oncology have led to clinical implementation of novel treatment modality. Stereotactic body radiotherapy (SBRT)/stereotactic ablative body radiotherapy (SABR) is an emerging treatment paradigm as a result of image-guidance technology and more sophisticated computational treatment planning system.
Hua Ren, Shanda Blackmon, Bin S. Teh
openaire   +1 more source

Stereotactic Ablative Radiotherapy for Lung Cancers

2016
Surgery is the treatment of choice in patients with early-stage non-small cell lung cancer (NSCLC). However, in patients who are medically inoperable or refuse to undergo surgery, radiotherapy (RT) is the alternative option. Although studies with conventional RT have revealed unsatisfactory results, stereotactic ablative RT (SABR) offers similar ...
Gokhan Ozyigit, Sezin Yuce Sari, Gozde Yazici, Pervin Hurmuz, Melis Gultekin   +4 more
openaire   +1 more source

Stereotactic Body Radiation and Stereotactic Ablative Radiotherapy Therapy for Cancers

Within the last decade, the radiation oncology community has witnessed increased adoption of hypo-fractionated, high-precision radiation therapy using stereotactic body radiation therapy (SBRT), also referred to as stereotactic ablative radiotherapy ...
openaire   +2 more sources

Historical Development of Stereotactic Ablative Radiotherapy

2012
Stereotactic radiosurgery (SRS) has been an effective modality for the treatment of benign and malignant cranial disease for over 50 years. Just as SRS revolutionized the practice of neurosurgery, stereotactic ablative radiotherapy (SAbR) in extracranial sites is now challenging conventional wisdom with regard to the practice of radiation oncology ...
Timothy D. Solberg, Robert L. Siddon, Brian Kavanagh   +2 more
openaire   +1 more source